Malmö, Sweden

Ola Neckling

This inventor holds 1 USPTO granted patent. Top assignee: Ganbro Lundia Ab. Active years: 2006.


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 39(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ola Neckling: Innovator in Infusion Monitoring Technology

Introduction

Ola Neckling is a notable inventor based in Malmö, Sweden. He has made significant contributions to the field of medical technology, particularly in the area of infusion monitoring. His innovative approach has led to the development of a unique device that enhances the efficiency and safety of infusion solutions.

Latest Patents

Ola Neckling holds a patent for a "Method and device for monitoring the flow speed of an infusion solution." This invention is particularly relevant for applications such as hemofiltration or hemodiafiltration. The device features a tube that conducts an infusion solution from a source to a pump device, such as a peristaltic or ceramic pump, and subsequently to an infusion device like a drip chamber. The flow speed is determined by the metering pump, while a pressure measurement across a restriction device in the tube allows for separate monitoring of the flow speed. The restriction device can either be a valve or a tube with a small internal diameter of approximately 0.5 mm. The pressure measuring device calculates the flow speed by accounting for the hydrostatic pressure from the infusion bag.

Career Highlights

Ola Neckling is currently employed at Ganbro Lundia AB, where he continues to innovate in the medical technology sector. His work focuses on improving the reliability and accuracy of infusion systems, which are critical in various medical treatments.

Collaborations

Ola collaborates with Björn Ericson, contributing to the advancement of their projects and enhancing the overall effectiveness of their innovations.

Conclusion

Ola Neckling's contributions to infusion monitoring technology exemplify the impact of innovative thinking in the medical field. His patent and ongoing work at Ganbro Lundia AB highlight his commitment to improving patient care through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…